000028 国药一致
2026/03 - 三个月
人民币(K¥)
2025/12
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
经营活动产生之现金流量净额(2,935,333)1,638,5893,271,4682,937,1392,560,431
投资活动产生之现金流量净额(23,215)(102,925)(150,686)(135,435)(342,819)
筹资活动产生之现金流量净额332,395(1,362,226)(1,831,236)(2,407,642)(1,507,760)
汇率变动对现金及现金等价物的影响(1)(74)(1,196)(941)(1,190)
现金及现金等价物净增加/(减少)(2,626,155)173,3641,288,350393,121708,661
期初现金及现金等价物余额7,297,0087,123,6455,835,2945,442,1734,733,512
期末现金及现金等价物余额4,670,8547,297,0087,123,6455,835,2945,442,173